ID: MRFR/MED/0669-HCR | February 2021 | Region: Global | 80 pages
Market Scenario
Absorbable Heart Stent Market is expected to register 11.8% CAGR during the forecast period of 2019 to 2025 and will achieve USD 428.4 Million in 2025. The market was valued at USD 264.6 million in 2018.
Stents are small expandable tubes that are used to inflate the arteries of the patient to prevent blockage. These are called heart stents or cardiac stents. Stents are inserted into the artery of a patient suffering from coronary disease due to the build-up of plaque. It is used for widening the narrowed arteries and aids in reducing chest pain and limiting chances of heart attack. These stents are widely used for the treatment of coronary and peripheral artery diseases.
Segmentation
The global absorbable heart stent has been segmented based on material, application, and end-use. The global market, based on material, has been divided into metal and polymer. The polymer segment is expected to be the largest segment owing to the increasing applications and use of polymer-based stents.
The global market, based on application, has been bifurcated into coronary artery disease and periphery artery disease. The coronary artery disease segment is the largest in terms of value due to prevalence of coronary diseases in geriatric individuals and is predicted to achieve more revenue in the upcoming absorbable heart stent market.
The global market, based on end use, has been segmented into hospitals & clinics, cardiovascular centers, research institutes and organizations, and others. Hospitals & clinics are the largest end users of absorbable heart stents. The segment is anticipated to hold a major share of the market during the forecast period. This is due to the increasing number heart surgeries and the growing risk of coronary artery disease (CAD) and peripheral artery disease (PAD).
The market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The absorbable heart stent in the Americas has further been divided into North America and Latin America. In North America, the market is bifurcated into the US and Canada. The European absorbable heart stent has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, Italy, Spain, the UK, and the rest of Western Europe. The absorbable heart stent in Asia-Pacific has been segmented into Japan, China, India, South Korea, and Australia. The absorbable heart stent in the Middle East & Africa has been divided into the Middle East and Africa.
Key Players
The key players in global absorbable heart stent are Abbott Laboratories, Biotronik, REVA Medical, Inc., Elixir Medical Corporation, B. Braun Melsungen AG, KYOTO MEDICAL PLANNING Co., Ltd., Boston Scientific Corporation, Medtronic, Terumo Medical Corporation, and Meril Life Sciences Pvt. Ltd.
Regional Market Summary
Global Absorbable Heart Stent Share (%), by Region, 2018
Source: World Health Organization (WHO), Institute of Medicine (IOM)
The market in the Americas is projected to have a steady growth rate during the forecast period owing to the increasing number of patients with chronic diseases and government initiatives for healthcare reforms. Moreover, there is an increase in the use of these stents by healthcare physicians. A patient’s preference for minimally invasive therapies is driving the growth of the absorbable heart stent market in this region.
The market in Europe showed substantial growth during the forecast period. The market growth in this region can be attributed due to the huge patient pool and prevalence of CAD and PAD. According to latest data from Centers for Disease Control and Prevention 11.3 million cardiovascular surgeries were carried out in this region in 2018.
The market in Asia-Pacific is expected to dominate the global absorbable heart stent due to the increase in development of healthcare infrastructures. Moreover, there is an increase in number of patients suffering from chronic disease, including cardiovascular disease. For instance, according to World Heart Federation, cardiovascular disease is estimated to account for 87% of total adult deaths in China in 2016.
The market in the Middle East & Africa is expected to grow at a substantial rate due to the increase in the use of surgical treatment for cardiovascular diseases in the region.
Global Absorbable Heart Stent Market, by Material
Global Absorbable Heart Stent Market by Application
Global Absorbable Heart Stent Market, by End-Use
Global Absorbable Heart Stent Market, by Region
Intended Audience
Report Attribute/Metric | Details |
---|---|
Market Size | USD 428.4 Million |
CAGR | 11.8% CAGR |
Base Year | 2019 |
Forecast Period | 2020-2027 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Material, Application and End-Use |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Abbott Laboratories, Biotronik, REVA Medical, Inc., Elixir Medical Corporation, B. Braun Melsungen AG, KYOTO MEDICAL PLANNING Co., Ltd., Boston Scientific Corporation, Medtronic, Terumo Medical Corporation, and Meril Life Sciences Pvt. Ltd |
Key Market Opportunities | Demand for absorbable heart stents is increasing due to advancement in technology of developing heart stents and increase in number of cardiac surgeries. |
Key Market Drivers |
|
TABLE OF CONTENTS
REPORT PROLOGUE
MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
GLOBAL ABSORBABLE HEART STENT MARKET, BY MATERIAL
6.1. Overview
6.2. Metal
Market Estimates & Forecast, by Region, 2019–2025
Market Estimates & Forecast, by Country, 2019–2025
6.3. Polymer
Market Estimates & Forecast, by Region, 2019–2025
Market Estimates & Forecast, by Country, 2019–2025
GLOBAL ABSORBABLE HEART STENT MARKET, BY APPLICATION
7.1. Overview
7.2. Coronary Artery Disease
Market Estimates & Forecast, by Region, 2019–2025
Market Estimates & Forecast, by Country, 2019–2025
7.3. Periphery Artery Disease
Market Estimates & Forecast, by Region, 2019–2025
Market Estimates & Forecast, by Country, 2019–2025
GLOBAL ABSORBABLE HEART STENT MARKET, BY END USE
8.1. Overview
8.2. Hospitals & Clinics
Market Estimates & Forecast, by Region, 2019–2025
Market Estimates & Forecast, by Country, 2019–2025
8.3. Research and Academic Institutes
Market Estimates & Forecast, by Region, 2019–2025
Market Estimates & Forecast, by Country, 2019–2025
8.4. Others
Market Estimates & Forecast, by Region, 2019–2025
Market Estimates & Forecast, by Country, 2019–2025
GLOBAL ABSORBABLE HEART STENT MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Absorbable Heart Stent Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Absorbable Heart Stent Market
10.7. Key developments and Growth Strategies
10.7.1. Product Launch/Service Deployment
10.7.2. Mergers and Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix & Market Ratio
10.8.1. Sales & Operating Income 2020
10.8.2. Major Players R&D Expenditure 2020
10.9. Major Players Capital Market Ratio
COMPANY PROFILES
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Overview
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Biotronik
11.2.1. Company Overview
11.2.2. Product Overview
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. REVA Medical, Inc.
11.3.1. Company Overview
11.3.2. Product Overview
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Elixir Medical Corporation
11.4.1. Company Overview
11.4.2. Product Overview
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Medtronic
11.5.1. Company Overview
11.5.2. Product Overview
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. KYOTO MEDICAL PLANNING Co., Ltd.
11.6.1. Company Overview
11.6.2. Product Overview
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Boston Scientific Corporation
11.7.1. Company Overview
11.7.2. Product Overview
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Terumo Medical Corporation
11.8.1. Company Overview
11.8.2. Product Overview
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Meril Life Sciences Pvt. Ltd
11.9.1. Company Overview
11.9.2. Product Overview
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. B. Braun Melsungen AG
11.10.1. Company Overview
11.10.2. Product Overview
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Others
APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ABSORBABLE HEART STENT MARKET SYNOPSIS, 2019–2025
TABLE 2 GLOBAL ABSORBABLE HEART STENT MARKET ESTIMATES & FORECAST, 2020-2027(USD MILLION)
TABLE 3 GLOBAL ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)
TABLE 4 GLOBAL ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 5 GLOBAL ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)
TABLE 6 GLOBAL ABSORBABLE HEART STENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 7 NORTH AMERICA: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)
TABLE 8 NORTH AMERICA: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 9 NORTH AMERICA: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)
TABLE 10 US: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)
TABLE 11 US: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 12 US: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)
TABLE 13 CANADA: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)
TABLE 14 CANADA: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 15 CANADA: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)
TABLE 16 LATIN AMERICA: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)
TABLE 17 LATIN AMERICA: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 18 LATIN AMERICA: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)
TABLE 19 EUROPE: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)
TABLE 20 EUROPE: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 21 EUROPE: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)
TABLE 22 WESTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)
TABLE 23 WESTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 24 WESTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)
TABLE 25 EASTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)
TABLE 26 EASTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 27 EASTERN EUROPE: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)
TABLE 28 ASIA-PACIFIC: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)
TABLE 29 ASIA-PACIFIC: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 30 ASIA-PACIFIC: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: ABSORBABLE HEART STENT MARKET, BY MATERIAL, 2020-2027(USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: ABSORBABLE HEART STENT MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: ABSORBABLE HEART STENT MARKET, BY END USE, 2020-2027(USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ABSORBABLE HEART STENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ABSORBABLE HEART STENT MARKET
FIGURE 4 GLOBAL ABSORBABLE HEART STENT MARKET SHARE, BY MATERIAL, 2020 (%)
FIGURE 5 GLOBAL ABSORBABLE HEART STENT MARKET SHARE, BY APPLICATION, 2020 (%)
FIGURE 6 GLOBAL ABSORBABLE HEART STENT MARKET SHARE, BY END USE, 2020 (%)
FIGURE 7 GLOBAL ABSORBABLE HEART STENT MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 AMERICAS: ABSORBABLE HEART STENT MARKET SHARE BY REGION, 2020 (%)
FIGURE 9 NORTH AMERICA: ABSORBABLE HEART STENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 10 EUROPE: ABSORBABLE HEART STENT MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 WESTERN EUROPE: ABSORBABLE HEART STENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 ASIA-PACIFIC: ABSORBABLE HEART STENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 13 MIDDLE EAST & AFRICA: ABSORBABLE HEART STENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 14 GLOBAL ABSORBABLE HEART STENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 15 ABBOTT LABORATORIES.: KEY FINANCIALS
FIGURE 16 ABBOTT LABORATORIES: SEGMENTAL REVENUE
FIGURE 17 ABBOTT LABORATORIES: REGIONAL REVENUE
FIGURE 18 BIOTRONIK: KEY FINANCIALS
FIGURE 19 BIOTRONIK: SEGMENTAL REVENUE
FIGURE 20 BIOTRONIK: REGIONAL REVENUE
FIGURE 21 REVA MEDICAL, INC.: KEY FINANCIALS
FIGURE 22 REVA MEDICAL, INC.: SEGMENTAL REVENUE
FIGURE 23 REVA MEDICAL, INC.: REGIONAL REVENUE
FIGURE 24 ELIXIR MEDICAL CORPORATION: KEY FINANCIALS
FIGURE 25 ELIXIR MEDICAL CORPORATION: SEGMENTAL REVENUE
FIGURE 26 ELIXIR MEDICAL CORPORATION: REGIONAL REVENUE
FIGURE 27 MEDTRONIC: KEY FINANCIALS
FIGURE 28 MEDTRONIC: SEGMENTAL REVENUE
FIGURE 29 MEDTRONIC: REGIONAL REVENUE
FIGURE 30 KYOTO MEDICAL PLANNING CO., LTD: KEY FINANCIALS
FIGURE 31 KYOTO MEDICAL PLANNING CO., LTD: SEGMENTAL REVENUE
FIGURE 32 KYOTO MEDICAL PLANNING CO., LTD: REGIONAL REVENUE
FIGURE 33 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: SEGMENTAL REVENUE
FIGURE 35 BOSTON SCIENTIFIC CORPORATION: REGIONAL REVENUE
FIGURE 36 TERUMO MEDICAL CORPORATION: KEY FINANCIALS
FIGURE 37 TERUMO MEDICAL CORPORATION: SEGMENTAL REVENUE
FIGURE 38 TERUMO MEDICAL CORPORATION: REGIONAL REVENUE
FIGURE 39 MERIL LIFE SCIENCES PVT. LTD: KEY FINANCIALS
FIGURE 40 MERIL LIFE SCIENCES PVT. LTD: SEGMENTAL REVENUE
FIGURE 41 MERIL LIFE SCIENCES PVT. LTD: REGIONAL REVENUE
FIGURE 42 B. BRAUN MELSUNGEN AG: KEY FINANCIALS
FIGURE 43 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE
FIGURE 44 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE